Bayer (FRA:BAYN) Given a €77.00 Price Target at Goldman Sachs Group

Goldman Sachs Group set a €77.00 ($89.53) target price on Bayer (FRA:BAYN) in a research note released on Tuesday morning, Borsen Zeitung reports. The firm currently has a buy rating on the healthcare company’s stock.

BAYN has been the subject of several other research reports. Sanford C. Bernstein set a €90.00 ($104.65) price target on shares of Bayer and gave the stock a buy rating in a research report on Thursday, July 18th. Baader Bank set a €123.00 ($143.02) price target on shares of Bayer and gave the stock a buy rating in a research report on Tuesday, July 23rd. Barclays set a €85.00 ($98.84) price target on shares of Bayer and gave the stock a buy rating in a research report on Friday, May 24th. HSBC set a €63.00 ($73.26) price target on shares of Bayer and gave the stock a neutral rating in a research report on Monday, July 1st. Finally, Berenberg Bank set a €67.00 ($77.91) price target on shares of Bayer and gave the stock a neutral rating in a research report on Tuesday, June 11th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and twelve have assigned a buy rating to the company. Bayer has a consensus rating of Hold and a consensus target price of €80.61 ($93.73).

BAYN opened at €58.00 ($67.44) on Tuesday. Bayer has a twelve month low of €91.58 ($106.49) and a twelve month high of €123.82 ($143.98). The stock’s 50-day moving average is €58.37.

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

See Also: What is the return on assets formula?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.